We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Method Isolates Neuron-Linked Vesicles From Blood and Cerebrospinal Fluid

By LabMedica International staff writers
Posted on 03 Nov 2026

Neurological and neuropsychiatric disorders such as Parkinson’s disease, Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS) are often diagnosed only after symptoms emerge. More...

By that stage, underlying disease processes in the brain and nervous system may already be advanced. Because brain biopsy is limited by accessibility, there is growing interest in biomarkers that can be measured in biofluids. Building on this approach, researchers now report a framework for isolating neuron-specific extracellular vesicles from blood and cerebrospinal fluid.

The Wyss Institute at Harvard University developed the approach in collaboration with Brigham and Women’s Hospital, the Broad Institute of MIT and Harvard, and Harvard Medical School. The work focuses on extracellular vesicles, membrane-enclosed particles released by cells into biofluids that carry RNA transcripts and proteins. Because neuron-specific extracellular vesicles make up only a very small fraction of vesicles in plasma and other biofluids, the researchers developed methods to identify surface markers that could enable antibody-based isolation.

The team first established a method for isolating the full spectrum of extracellular vesicles from plasma and other body fluids at high purity. The technique uses porous beads that trap and remove free proteins such as albumin while excluding larger extracellular vesicles. According to the researchers, this one-step procedure increased extracellular vesicle purity by an additional 100-fold.

Using mass spectrometry, the researchers then generated reference proteomes for extracellular vesicles from plasma and cerebrospinal fluid. They combined these data with computational analysis of single-cell RNA sequencing studies to prioritize predicted transmembrane proteins whose genes were selectively expressed in neurons. One candidate marker, NRXN3, was confirmed on extracellular vesicles from both plasma and cerebrospinal fluid using ultrasensitive SIMOA detection assays and single-vesicle imaging methods.

The proof-of-concept study was published in Nature Neuroscience on October 23, 2026. The team also developed and validated an immuno-isolation method that reliably isolated NRXN3-carrying extracellular vesicles from human cerebrospinal fluid and plasma samples. The findings provide a framework for further analysis of proteins contained within neuron-derived extracellular vesicles and for identifying additional extracellular vesicle markers associated with other cell types and tissues.

“This project is a significant step towards our goal of reading out the brains of patients through the contents of neuron-specific EVs. We are now measuring specific proteins inside of these EVs to confirm their neuronal origin. Our goal is to look inside neuron-derived EVs for markers that are correlated with earlier stages and the progression of neurological disorders, as well as therapeutic efficacy of present and future drug candidates. More fundamentally, such markers can also help us better understand some of the underlying early pathologies, which for many neurological disorders are not clear at all,” said David Walt, Core Faculty member at the Wyss Institute.

Related Links
Wyss Institute at Harvard University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.